(Q36467696)

14 August 2017

Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications (English)

1 reference

adenocarcinoma of the lung

14 August 2017

1 reference

1 reference

Sørensen JB

1

1 reference

14 August 2017

Badsberg JH

series ordinal

2

1 reference

14 August 2017

Hansen HH

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 September 1989

1 reference

14 August 2017

5

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

14 August 2017

60

1 reference

14 August 2017

3

1 reference

14 August 2017

389-393

1 reference

The prognostic implication of histopathologic subtyping of pulmonary adenocarcinoma according to the classification of the World Health Organization. An analysis of 259 consecutive patients with advanced disease

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Combination chemotherapy for advanced adenocarcinoma of the lung. A review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Analysis of survival by tumor response.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247192

Evaluation of response criteria in advanced lung cancer

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2789948

12 December 2020

inferred from PubMed ID database lookup

Commentary: current status of chemotherapy for non-small cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2789948

12 December 2020

inferred from PubMed ID database lookup

Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2789948

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1989.291

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

2789948

1 reference